GLP-1 & Obesity
GLP-1 medicines treat obesity and diabetes, and have grown into one of the largest drug categories ever launched. Their reach extends past medicine, because a change in how much people eat moves whole consumer industries.
92 stocks
| # | Name | Holding | Trade Value |
Theme Stocks |
% of Portfolio | Status | |
|---|---|---|---|---|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
| $125B | +$2.14B | 60 | 2.47% | Increased |
|
| 2 |
BlackRock
New York
| $113B | +$215M | 67 | 2.63% | Increased |
|
| 3 |
Lilly Endowment
Indiananapolis,
Indiana
| $76.9B | -$619M | 1 | 100% | Reduced |
|
| 4 |
State Street
Boston,
Massachusetts
| $62.3B | +$451M | 65 | 2.79% | Increased |
|
| 5 |
Fidelity Investments
Boston,
Massachusetts
| $48.9B | +$2.27B | 56 | 3.29% | Increased |
|
| 6 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| $40.9B | -$231M | 54 | 28.4% | Reduced |
|
| 7 |
JP Morgan Chase
New York
| $30.7B | +$619M | 65 | 2.59% | Increased |
|
| 8 |
T. Rowe Price Associates
Baltimore,
Maryland
| $30.1B | -$1.42B | 49 | 3.69% | Reduced |
|
| 9 |
Capital World Investors
Los Angeles,
California
| $28.7B | -$4.19B | 9 | 4.76% | Reduced |
|
| 10 |
Geode Capital Management
Boston,
Massachusetts
| $28.2B | +$645M | 66 | 2.61% | Increased |
|
| 11 |
Morgan Stanley
New York
| $26.5B | +$523M | 70 | 2.13% | Increased |
|
| 12 |
Primecap Management
Pasadena,
California
| $23.9B | -$693M | 6 | 17.86% | Reduced |
|
| 13 |
Wellington Management Group
Boston,
Massachusetts
| $20.6B | -$2.42B | 32 | 3.65% | Reduced |
|
| 14 |
Bank of America
Charlotte,
North Carolina
| $17.9B | +$1.13B | 63 | 1.63% | Increased |
|
| 15 |
Norges Bank
Oslo,
Norway
| $16.8B | +$761M | 26 | 2.65% | Increased |
|
| 16 |
Northern Trust
Chicago,
Illinois
| $14.9B | -$592M | 65 | 2.58% | Reduced |
|
| 17 |
Capital International Investors
Los Angeles,
California
| $14.2B | +$1.81B | 12 | 2.87% | Increased |
|
| 18 |
Bank of New York Mellon
New York
| $13.5B | -$92.6M | 53 | 2.59% | Reduced |
|
| 19 |
State Farm Mutual Automobile Insurance
Bloomington,
Illinois
| $13.2B | -$2.64B | 6 | 11.88% | Reduced |
|
| 20 |
Charles Schwab
San Francisco,
California
| $12.8B | +$808M | 53 | 2.96% | Increased |
|
| 21 |
Franklin Resources
San Mateo,
California
| $10.6B | +$4.07B | 37 | 3.37% | Increased |
|
| 22 |
Jennison Associates
New York
| $10.1B | -$325M | 12 | 6.75% | Reduced |
|
| 23 |
Legal & General Group
London,
United Kingdom
| $9.57B | -$67.4M | 49 | 2.76% | Reduced |
|
| 24 |
Goldman Sachs
New York
| $9.2B | +$77M | 54 | 1.63% | Increased |
|
| 25 |
Invesco
Atlanta,
Georgia
| $9.12B | +$35.6M | 49 | 1.96% | Increased |
|